Natco Pharma Ltd. NSE: NATCOPHARM | BSE: 524816

Strong Performer, Under Radar

Download real time

839.80 -6.00 (-0.71%)

44.20% Fall from 52W High

414.6K

NSE+BSE Volume

NSE 13 Oct, 2025 3:31 PM (IST)

HC Order

Delhi HC upholds its order allowing Natco to market a generic version of Roche's Risdiplam in India See details

Natco Pharma Ltd. News and Updates

Name: Latest research reports of Natco Pharma Ltd. authored by Reliance Securities and published by - Trendlyne research reports.
Item: Natco Pharma Ltd.
Rating: 5
Author: Reliance Securities

Keep track of all breaking news on Natco Pharma Ltd. from all sources in a single place.

Load latest

Is Natco Pharma Ltd. worth buying?

577 Votes:

Buy 83.02%

Sell 7.28%

Hold 9.71%

RESEARCH REPORTS

Hold SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf